The Journal of Urology
Volume 183, Issue 2 , Pages 430-432 , February 2010

Transvaginal Mesh for Cystocele Repair

  • Howard B. Goldman

      Affiliations

    • Center for Female Pelvic Medicine and Reconstructive Surgery, Glickman Urologic and Kidney Institute, The Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio
    • Financial and/or other relationship with Pfizer, Novartis, Astellas, Johnson and Johnson, American Medical Systems, Endogun Medical Systems and Allergan.
    • ,
  • Mary P. FitzGerald

      Affiliations

    • Department of Obstetrics and Gynecology, Department of Urology, Loyola University Medical Center, Maywood, Illinois

References 

  1. Nguyen JN, Burchette RJ. Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol. 2008;111:891
  2. Hiltunen R, Nieminen K, Takala T, et al. Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial. Obstet Gynecol. 2007;110:455
  3. Jia X, Glazener C, Mowatt G, et al. Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systematic review and meta-analysis. BJOG. 2008;115:1350
  4. Altman D, Elmer C, Kiilholma P, et al. Sexual dysfunction after trocar-guided transvaginal mesh repair of pelvic organ prolapse. Obstet Gynecol. 2009;113:127
  5. Salvatore S, Athanasiou S, Digesu GA, et al. Identification of risk factors for genital prolapse recurrence. Neurourol Urodynam. 2009;28:301
  6. Olsen AE, Smith VJ, Begstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501

PII: S0022-5347(09)03041-9

doi: 10.1016/j.juro.2009.11.074

The Journal of Urology
Volume 183, Issue 2 , Pages 430-432 , February 2010

Article Tools